Mode
Text Size
Log in / Sign up
Phase 4 Completed N=643 Randomized Single-blind Treatment

A Multi-site Randomized Controlled Trial Comparing Regional and General Anesthesia for Effects on Neurodevelopmental Outcome and Apnea in Infants

Source: ClinicalTrials.gov NCT00756600 ↗
Enrolled (actual)
643
Serious AEs
Results posted
Apr 2020
Primary outcomePrimary: Full Scale IQ Score — 100.5; 100.1 score on scale
◆ Published Evidence
Highly cited
1,131citations · ~113 / year
Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial.
Lancet (London, England) · 2016 · Open access · Likely link

Summary

The primary purpose of the GAS study is to determine whether different types of anesthesia (Regional versus General) given to 720 infants undergoing inguinal hernia repair results in equivalent neurodevelopmental outcomes. The study also aims to describe the incidence of apnea in the post-operative period after both regional and general anesthesia for inguinal hernia repair in infants. This study is important as it will provide the greatest evidence for safety or toxicity of general anesthesia for human infants.

Linked Publications (2)

  • Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial.
    Lancet (London, England) · 2016 · 1,131 citations · Open access · Likely link
  • Neurodevelopmental outcome at 5 years of age after general anaesthesia or awake-regional anaesthesia in infancy (GAS): an international, multicentre, randomised, controlled equivalence trial.
    Lancet (London, England) · 2019 · 734 citations · Open access · Likely link

Outcome Measures

OutcomeResultp-value
PRIMARY
Full Scale IQ Score
100.5; 100.1
SECONDARY
Verbal IQ
101.8; 100.9
SECONDARY
Performance IQ
100.7; 101.2
SECONDARY
Processing Speed Quotient
95.8; 96.3
SECONDARY
Sentence Repetition Scaled Score
9.7; 9.7
SECONDARY
Auditory Attention Combined Scaled Score
9.0; 9.3
SECONDARY
Statue Scaled Score
8.8; 8.6
SECONDARY
Inhibition Combined Scaled Score
8.3; 8.9
SECONDARY
Word Generation Scaled Score
9.4; 9.3
SECONDARY
Affect Recognition Scaled Score
10.6; 10.4
SECONDARY
Memory for Names and Memory for Names Delay
8.1; 8.1
SECONDARY
Theory of Mind Scaled Score
9.8; 9.3
SECONDARY
Speeded Naming Combined Scaled Score
9.7; 9.8
SECONDARY
Fingertip Tapping Repetitions Scaled Score
9.8; 9.7
SECONDARY
Fingertip Tapping Sequences Scaled Score
8.1; 7.7
SECONDARY
Design Copy Process Total Scaled Score
9.6; 9.9
SECONDARY
Word Reading Standard Score
92.3; 92.8
SECONDARY
Numerical Operations Standard Score
98.8; 96.2
SECONDARY
Spelling Standard Score
90.1; 90.8
SECONDARY
Numbers Total Scaled Score
8.3; 8.1
SECONDARY
Word Lists 1 (Learning) Scaled Score
8.3; 8.6
SECONDARY
Memory and Learning Word Lists II (Delayed) Scaled Score
9.7; 9.6
SECONDARY
The Global Executive Composite (GEC) of the Behaviour Rating of Executive Function
48.4; 51.5
SECONDARY
The Global Adaptive Composite (GAC) of the Adaptive Behavior Assessment System
95.9; 94.1
SECONDARY
Total Problems Score
44.6; 46.7
SECONDARY
Internalising Problems T Score
46.1; 48.0
SECONDARY
Externalising Problems T Score
44.0; 45.8
SECONDARY
Speech or Language Interventions
18; 17
SECONDARY
Psychomotor Interventions
8; 6
SECONDARY
Number of Participants With Global Developmental Delay
2; 0
SECONDARY
Number of Participants With Attention Deficit Hyperactivity Disorder
3; 4
SECONDARY
Number of Participants With Autism Spectrum Disorder
5; 11
SECONDARY
Number of Participants With a Hearing Abnormality
8; 11
SECONDARY
Number of Participants With a Visual Defect in Either Eye
21; 31
SECONDARY
Number of Participants With a Hearing Aid
0; 3
SECONDARY
Number of Participants Who Are Legally Blind
0; 0
SECONDARY
Number of Participants Who Have Cerebral Palsy
1; 3
SECONDARY
Parents' Awareness of Group Allocation
105; 118
SECONDARY
Awareness of Group Allocation by Psychologist
7; 7
SECONDARY
Awareness of Group Allocation by Pediatrician
13; 13

Eligibility Criteria

Inclusion Criteria

  • Any infant scheduled for unilateral or bilateral inguinal hernia repair (with or without circumcision)
  • Any infant whose gestational age is 26 weeks or more (GA = 182 days)
  • Any infant whose post-menstrual age is up to 60 weeks (PMA = 426 days)

Exclusion Criteria

  • Any child older than 60 weeks post-menstrual age
  • Any child born less than 26 weeks gestation
  • Any contraindication to general or spinal/caudal anesthesia (for example: neuromuscular disorder or coagulopathy)
  • Pre-operative ventilation immediately prior to surgery
  • Congenital heart disease that has required ongoing pharmacotherapy
  • Known chromosomal abnormality or any other known acquired or congenital abnormalities (apart from prematurity) which are likely to affect development
  • Children where follow-up would be difficult for geographic or social reasons
  • Families where English is not the primary language spoken at home
  • Known neurological injury such as cystic periventricular leukomalacia (PVL), or grade 3 or 4 intra ventricular hemorrhage (ICH) (+/- post hemorrhage ventricular dilation)
  • Previous exposure to volatile anesthesia or benzodiazepines as a neonate or in the third trimester in utero.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00756600) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search